Po-Cheng Lin Selected Research

Po-Cheng Lin Research Topics

Disease

9	Neoplasms (Cancer) 05/2014 - 11/2007
6	Liver Cirrhosis (Hepatic Cirrhosis) 12/2019 - 09/2009
4	Fibrosis (Cirrhosis) 11/2020 - 01/2015
4	Glioblastoma (Glioblastoma Multiforme) 11/2011 - 08/2008
3	Stroke (Strokes) 01/2022 - 01/2013
3	Myocardial Infarction 12/2021 - 01/2017
3	Infarction (Infarctions) 11/2020 - 01/2014
3	Brain Neoplasms (Brain Tumor) 05/2014 - 08/2008
2	Inflammation (Inflammations) 11/2020 - 01/2016
2	Hepatocellular Carcinoma (Hepatoma) 02/2010 - 10/2008
2	Colorectal Neoplasms (Colorectal Cancer) 04/2009 - 02/2009
2	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 04/2009 - 02/2009
1	Knee Osteoarthritis 01/2024
1	Osteoarthritis 04/2023
1	Hyperglycemia 01/2022
1	Ischemic Stroke 01/2022
1	Cognitive Dysfunction 12/2021
1	Hypertension (High Blood Pressure) 10/2019
1	Cardiomegaly (Heart Hypertrophy) 10/2019
1	Liver Diseases (Liver Disease) 01/2015
1	Wounds and Injuries (Trauma) 01/2014
1	Prostatic Neoplasms (Prostate Cancer) 04/2013
1	Neointima 10/2011
1	Hyperplasia 10/2011
1	Glioma (Gliomas) 06/2011
1	Osteoporosis 01/2011
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2011
1	Lung Neoplasms (Lung Cancer) 11/2007
1	Carcinoma (Carcinomatosis) 11/2007

Drug/Important Bio-Agent (IBA)

11	butylidenephthalideIBA 11/2020 - 08/2008
2	SolutionsIBA 12/2019 - 01/2015
2	Thioacetamide (Thioacetamid)IBA 01/2017 - 01/2015
2	Therapeutic UsesIBA 01/2016 - 01/2015
2	isochaihulactoneIBA 04/2013 - 11/2007
2	Fluorouracil (Carac)FDA LinkGeneric 04/2009 - 02/2009
2	Chloroform (Trichloromethane)IBA 10/2008 - 08/2008
2	Orphan Nuclear ReceptorsIBA 10/2008 - 08/2008
2	Mitogen-Activated Protein KinasesIBA 10/2008 - 11/2007
1	AlginatesIBA 04/2023
1	Streptozocin (Streptozotocin)FDA Link 01/2022
1	Insulin (Novolin)FDA Link 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2021
1	InflammasomesIBA 11/2020
1	Nerve Growth Factor (NGF)IBA 01/2017
1	ligustilideIBA 01/2016
1	S-Phase Kinase-Associated Proteins (Skp1 Protein)IBA 05/2014
1	Androgen Receptors (Androgen Receptor)IBA 04/2013
1	AndrogensIBA 04/2013
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2013
1	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2011
1	Messenger RNA (mRNA)IBA 11/2011
1	Caspase 3 (Caspase-3)IBA 10/2011
1	decanedioic acid- 4,4'- (1,3- propanediylbis(oxy))bis(benzoic acid) copolymerIBA 06/2011
1	PolymersIBA 06/2011
1	Plant ExtractsIBA 01/2011
1	Carmustine (FIVB)FDA Link 02/2010
1	MethyltransferasesIBA 02/2010
1	O-(6)-methylguanineIBA 02/2010
1	Matrix Metalloproteinases (MMPs)IBA 09/2009
1	DNA (Deoxyribonucleic Acid)IBA 02/2009
1	O(6)-Methylguanine-DNA MethyltransferaseIBA 02/2009
1	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 10/2008
1	Glycogen Synthase (Synthase I)IBA 10/2008
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 10/2008
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 10/2008
1	Protein Kinase CIBA 10/2008
1	LignansIBA 11/2007
1	OligodeoxyribonucleotidesIBA 11/2007
1	Mitogen-Activated Protein Kinase 3IBA 11/2007

Therapy/Procedure

8	Transplantation 01/2022 - 01/2012
7	Therapeutics 01/2022 - 04/2013
2	Liver Transplantation 12/2019 - 01/2015
2	Adjuvant Chemotherapy 04/2009 - 02/2009
1	Intra-Articular Injections 01/2024
1	Stem Cell Transplantation 11/2020
1	Cell- and Tissue-Based Therapy (Cell Therapy) 10/2008
1	Drug Therapy (Chemotherapy) 08/2008